Formulation and Evaluation of Iornoxicam as Dissolving Microneedle Patch
The objective of the study was to develop microneedle (MN) patch, with suitable properties to ensure the delivery of a therapeutic level of lornoxicam (LXM) in a period suitable to replace parenteral administration in patients, especially those who fear needles. The used polymers were cold water-sol...
Saved in:
Main Authors: | Adeeb R. Alkhiro (Author), Mowafaq M. Ghareeb (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy University of Baghdad,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Formulation, in vitro and in vivo evaluation of olanzapine nanoparticles dissolving microneedles for transdermal delivery
by: Abulfadhel J. Neamah Al-Shaibani, et al.
Published: (2024) -
Dissolving Microneedle Patches as Vaccine Delivery Platforms
by: Muhammad Sohail Arshad, et al.
Published: (2023) -
Pharmacokinetic Evaluation of a Novel Donepezil-Loaded Dissolving Microneedle Patch in Rats
by: Naveed Ur Rehman, et al.
Published: (2021) -
Development of Novel Faster-Dissolving Microneedle Patches for Transcutaneous Vaccine Delivery
by: Akihiko Ono, et al.
Published: (2017) -
Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis
by: Weiman Zhao, et al.
Published: (2023)